Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea

Spring, 2000, Erythroid cell adhesion molecules, Transfus Med Rev, 14, 351, 10.1053/tmrv.2000.16231

Cartron, 2001, Structural and functional diversity of blood group antigens, Transfus Clin Biol, 8, 163, 10.1016/S1246-7820(01)00142-2

Reid, 2004, Red blood cell blood group antigens: structure and function, Semin Hematol, 41, 93, 10.1053/j.seminhematol.2004.01.001

Telen, 2005, Erythrocyte adhesion receptors: blood group antigens and related molecules, Transfus Med Rev, 19, 32, 10.1016/j.tmrv.2004.09.006

Chan, 2001, Adhesion receptors on hematopoietic progenitor cells, Br J Haematol, 112, 541, 10.1046/j.1365-2141.2001.02439.x

Hanspal, 1997, Importance of cell-cell interactions in regulation of erythropoiesis, Cur Op Hematol, 4, 142, 10.1097/00062752-199704020-00011

Manwani, 2008, The erythroblastic island, Curr Top Dev Biol, 82, 23, 10.1016/S0070-2153(07)00002-6

Ihanus, 2007, Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4, Blood, 109, 802, 10.1182/blood-2006-04-014878

Oldenborg, 2000, Role of CD47 as a marker of self on red blood cells, Science, 288, 2051, 10.1126/science.288.5473.2051

Coste, 2001, Unavailability of CD147 leads to selective erythrocyte trapping in the spleen, Blood, 97, 3984, 10.1182/blood.V97.12.3984

Telen, 2000, Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease, Semin Hematol, 37, 130, 10.1016/S0037-1963(00)90038-6

Miller, 2002, The pathogenic basis of malaria, Nature, 415, 673, 10.1038/415673a

Wautier, 2004, Protein glycation: a firm link to endothelial dysfunction, Circ Res, 95, 233, 10.1161/01.RES.0000137876.28454.64

Cines, 1998, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, 91, 3527

Le Van Kim, 2006, Rh proteins: key structural and functional components of the red cell membrane, Blood Rev, 20, 93, 10.1016/j.blre.2005.04.002

Springer TA, 1990, Adhesion receptors of the immune system, Nature, 346, 425, 10.1038/346425a0

Aricescu, 2007, Immunoglobulin superfamily cell adhesion molecules: zippers and signals, Curr Op Cell Biol, 19, 543, 10.1016/j.ceb.2007.09.010

Luo, 2007, Structural basis of integrin regulation and signaling, Annu Rev Immunol, 25, 619, 10.1146/annurev.immunol.25.022106.141618

Takada, 2007, The integrins, Genome Biol, 8, 215, 10.1186/gb-2007-8-5-215

Sugihara, 1992, Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells, Blood, 80, 2634, 10.1182/blood.V80.10.2634.2634

Joneckis, 1993, Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia, Blood, 82, 3548, 10.1182/blood.V82.12.3548.3548

Swerlick, 1993, Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium, Blood, 82, 1891, 10.1182/blood.V82.6.1891.1891

Vitte, 2005, Regulation of cell adhesion, Clin Hemorheol Microcirc, 33, 167

Stuart, 2004, Sickle cell disease, Lancet, 364, 1343, 10.1016/S0140-6736(04)17192-4

Schnog, 2004, Sickle cell disease; a general overview, Neth J Med, 62, 364

Chui, 2001, Sickle cell disease: no longer a single gene disorder, Curr Op Pediatr, 13, 22, 10.1097/00008480-200102000-00004

Steinberg, 2006, Modifier genes in sickle cell anemia, Curr Op Hematol, 13, 131, 10.1097/01.moh.0000219656.50291.73

Serjeant, 1994, The painful crisis of homozygous sickle cell disease: clinical features, Br J Haematol, 87, 586, 10.1111/j.1365-2141.1994.tb08317.x

Serjeant, 1969, The irreversibly sickle cell: a determinant of hemolysis in sickle cell anemia, Br J Haematol, 17, 527, 10.1111/j.1365-2141.1969.tb01403.x

Billett, 1986, The percentage of dense red cells does not predict incidence of sickle cell painful crisis, Blood, 68, 301, 10.1182/blood.V68.1.301.301

Hoover, 1979, Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures, Blood, 54, 872, 10.1182/blood.V54.4.872.872

Hebbel, 1980, Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease, J Clin Invest, 65, 154, 10.1172/JCI109646

Hebbel, 1980, Erythrocyte adherence to endothelium in sickle cell anemia. A possible determinant of disease severity, N Engl J Med, 302, 992, 10.1056/NEJM198005013021803

Hebbel, 1981, Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders, Blood, 58, 947, 10.1182/blood.V58.5.947.947

Opkala, 2004, The intriguing contribution of white blood cells to sickle cell disease: a red cell disorder, Blood Rev, 18, 65, 10.1016/S0268-960X(03)00037-7

Hebbel, 2004, The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy, Microcirc, 11, 129, 10.1080/mic.11.2.129.151

Platt, 1994, Mortality in sickle cell disease. Life expectancy and risk factors for early death, N Engl J Med, 330, 1639, 10.1056/NEJM199406093302303

Turhan, 2002, Primary role of adherent leukocytes in sickle cell vascular occlusion: a new paradigm, Proc Natl Acad Sci USA, 99, 3047, 10.1073/pnas.052522799

Finnegan, 2007, Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion, Am J Hematol, 82, 266, 10.1002/ajh.20819

Wun, 1999, Platelet-erythrocyte adhesion in sickle cell disease, J Invest Med, 47, 121

Wun, 2002, Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease, Clin Lab Haematol, 24, 81, 10.1046/j.1365-2257.2002.t01-1-00433.x

Brittain, 2007, Cytokines and plasma factors in sickle cell disease, Curr Opin Hematol, 14, 438, 10.1097/MOH.0b013e3282a4a673

Frenette, 2004, Sickle cell adhesion: heterotypic, multicellular aggregations driven by leukocyte adhesion, Microcirc, 11, 167, 10.1080/mic.11.2.167.177

Hillery, 2004, Pathophysiology of stroke in sickle cell disease, Microcirc, 11, 195, 10.1080/10739680490278600

Gladwin, 2006, Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation, Adv Exp Med Biol, 588, 189, 10.1007/978-0-387-34817-9_17

Mack, 2006, Sickle cell disease and nitric oxide: a paradigm shift?, Int J Biochem Cell Biol, 38, 1237, 10.1016/j.biocel.2006.01.010

Ergul, 2004, Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction, Am J Hematol, 76, 245, 10.1002/ajh.20107

Rivera, 2007, Reduced sickle erythrocyte dehydration in vivo by endothelin-1 receptor antagonists, Am J Physiol Cell Physiol, 293, C960, 10.1152/ajpcell.00530.2006

Sabaa, 2008, Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle cell disease, J Clin Invest, 10.1172/JCI33308

Kaul, 1996, The pathophysiology of vascular obstruction in the sickle syndromes, Blood Rev, 10, 29, 10.1016/S0268-960X(96)90018-1

Frenette, 2002, Sickle cell vaso-occlusion: multistep and multicellular paradigm, Curr Op Hematol, 9, 101, 10.1097/00062752-200203000-00003

De Franceschi, 2004, Established and experimental treatments for sickle cell disease, Haematologica, 89, 348

Steinberg, 2006, Pathophysiologically based drug treatment of sickle cell disease, Trends Pharmacol Sci, 27, 204, 10.1016/j.tips.2006.02.007

Wang, 2007, The pathophysiology, prevention and treatment of stroke in sickle cell disease, Curr Op Hematol, 14, 191, 10.1097/MOH.0b013e3280ec5243

Hagar, 2008, Advances in clinical research in sickle cell disease, Br J Haematol, 141, 346, 10.1111/j.1365-2141.2008.07097.x

Lebensburger, 2008, Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease, Curr Opin Drug Discov Devel, 11, 225

Platt, 2008, Hydroxyurea for the treatment of sickle cell anemia, N Engl J Med, 358, 1362, 10.1056/NEJMct0708272

Josephson, 2007, Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines, Transfus Med Rev, 21, 118, 10.1016/j.tmrv.2006.11.003

Mohandas, 1985, Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins, J Clin Invest, 76, 1605, 10.1172/JCI112144

Hebbel, 1997, Adhesive interactions of sickle erythrocytes with endothelium, J Clin Invest, 99, 2561, 10.1172/JCI119442

Kaul, 2004, In vivo studies of sickle red blood cells, Microcirc, 11, 153

Chiang, 2005, Sickle cell vaso-occlusion, Hematol Oncol Clin North Am, 19, 771, 10.1016/j.hoc.2005.08.002

Higgins, 2007, Sickle cell vaso-occlusion and rescue in a microfluidic device, Proc Natl Acad Sci USA, 104, 20496, 10.1073/pnas.0707122105

Browne, 1996, CD36-positive stress reticulocytes in sickle cell disease, J Lab Clin Med, 127, 340, 10.1016/S0022-2143(96)90181-X

Gee, 1995, Sickle reticulocytes adhere to VCAM-1, Blood, 85, 268, 10.1182/blood.V85.1.268.bloodjournal851268

Kumar, 1996, Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin, Blood, 88, 4348, 10.1182/blood.V88.11.4348.bloodjournal88114348

Ge, 2005, CD36: a multiligand molecule, Lab Hematol, 11, 31, 10.1532/LH96.04056

Esemuede, 2004, The role of thrombospondin-1 in human disease, J Surg Res, 122, 135, 10.1016/j.jss.2004.05.015

Gupta, 1999, Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin, Biochim Biophys Acta, 1453, 63, 10.1016/S0925-4439(98)00085-4

Browne, 1996, Disturbance of plasma and platelet thrombospondin levels in sickle cell disease, Am J Hematol, 51, 296, 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R

Brown, 2001, Integrin-associated protein (CD47) and its ligands, Trends Cell Biol, 11, 130, 10.1016/S0962-8924(00)01906-1

Brittain, 2001, Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin, Blood, 97, 2159, 10.1182/blood.V97.7.2159

Brittain, 2001, Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction, J Clin Invest, 107, 1555, 10.1172/JCI10817

Brittain, 2004, Mechanism of CD47-induced α4β1 integrin activation and adhesion in sickle reticulocytes, J Biol Chem, 279, 42393, 10.1074/jbc.M407631200

Isenberg, 2008, Thrombospondins: from structure to therapeutics: Thrombospondin-1: a physiological regulator of nitric oxide signaling, Cell Mol Life Sci, 65, 728, 10.1007/s00018-007-7488-x

El Nemer, 1998, The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules, J Biol Chem, 273, 16686, 10.1074/jbc.273.27.16686

Udani, 1998, Basal cell adhesion molecule/Lutheran protein. The receptor critical for sickle cell adhesion to laminin, J Clin Invest, 101, 2550, 10.1172/JCI1204

Krishnan, 1999, Increased expression of Lutheran and LW glycoproteins on red blood cells from patients with sickle cell disease [abstract], Br J Haematol, 105, 64

Hermand, 2004, Integrin receptor specificity for human red cell ICAM-4 ligand. Critical residues for αIIβ3 and αVβ3 binding, Eur J Biochem, 271, 3729, 10.1111/j.1432-1033.2004.04313.x

Mankelow, 2004, Identification of critical amino-acid residues on the erythroid intercellular adhesion molecule-4 (ICAM-4) mediating adhesion to αV-integrins, Blood, 103, 1503, 10.1182/blood-2003-08-2792

Kikkawa, 2005, Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues, Connect Tissue Res, 46, 193, 10.1080/03008200500344074

Eyler, 2006, Lutheran glycoprote: a multifunctional adhesion receptor, Transfusion, 46, 668, 10.1111/j.1537-2995.2006.00779.x

Lee, 1998, Sickle cell adhesion to laminin: potential role for the alpha5 chain, Blood, 92, 2951, 10.1182/blood.V92.8.2951

Mankelow, 2007, The Laminin 511/521-binding site on the Lutheran blood group glycoprotein is located at the flexible junction of Ig domains 2 and 3, Blood, 110, 3398, 10.1182/blood-2007-06-094748

Delahunty, 2006, LW protein: a promiscuous integrin receptor activated by adrenergic signaling, Transfus Clin Biol, 13, 44, 10.1016/j.tracli.2006.02.022

Toivanen, 2007, Importance of molecular studies on major blood groups -Intercellular adhesion molecule-4, a blood group antigen involved in multiple cellular interactions, Biochim Biophys Acta

Lee, 2006, Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation, Blood, 108, 2064, 10.1182/blood-2006-03-006759

Hines, 2003, Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion, Blood, 101, 3281, 10.1182/blood-2001-12-0289

Zennadi, 2004, Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-αvβ3 interactions, Blood, 104, 3774, 10.1182/blood-2004-01-0042

Gauthier, 2005, Protein kinase A-dependent phosphorylation of Lutheran/basal cell adhesion molecule glycoprotein regulates cell adhesion to laminin alpha5, J Biol Chem, 280, 30055, 10.1074/jbc.M503293200

Murphy, 2005, Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU, Blood, 105, 3322, 10.1182/blood-2004-07-2881

El Nemer, 2007, Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell α4β1 integrin: role in adhesion of sickle red blood cells to endothelial cells, Blood, 109, 3544, 10.1182/blood-2006-07-035139

Eyler, 2008, beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion, Br J Haematol, 141, 105, 10.1111/j.1365-2141.2008.07008.x

Hoppe, 2004, Gene interactions and stroke risk in children with sickle cell anemia, Blood, 103, 2391, 10.1182/blood-2003-09-3015

Hillery, 1996, Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin, Blood, 87, 4879, 10.1182/blood.V87.11.4879.bloodjournal87114879

Matsui, 2001, P-selectin mediates the adhesion of sickle erythrocytes to the endothelium, Blood, 98, 1955, 10.1182/blood.V98.6.1955

Thevenin, 1997, Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro, Blood, 90, 4172, 10.1182/blood.V90.10.4172

Barabino, 1997, Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions, Blood, 89, 2560, 10.1182/blood.V89.7.2560

Wood, 1996, Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow cytometrc measurement and clinical association, Blood, 88, 1873, 10.1182/blood.V88.5.1873.1873

de Jong, 2001, Characterization of the phosphatidylserine-exposing subpopulation of sickle cells, Blood, 98, 860, 10.1182/blood.V98.3.860

Setty, 2002, Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion, Blood, 99, 1564, 10.1182/blood.V99.5.1564

GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 2000; 95:1293–300.

Setty, 2008, Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes, Blood, 15, 905, 10.1182/blood-2007-07-099465

Zen, 2004, B-CAM/LU expression and the role of B-CAM/LU activation in binding low- and high-density red cells to laminin in sickle cell disease, Am J Heamatol, 75, 63, 10.1002/ajh.10442

Lee, 2001, The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia, Blood, 98, 966, 10.1182/blood.V98.4.966

Kaul, 2000, Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor, Blood, 95, 368, 10.1182/blood.V95.2.368

Finnegan, 2007, Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vaso-occlusion, Am J Physiol Heart Circ Physiol, 293, H1038, 10.1152/ajpheart.01054.2006

Lutty, 2001, Inhibition of TNF-alpha-induced sickle RBC retention in retina by a VLA-4 agonist, Invest Ophthalmol Vis Sci, 42, 1349

Kaul, 2006, Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation, Am J Physiol Cell Physiol, 291, C922, 10.1152/ajpcell.00639.2005

Zennadi, 2007, Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo, Blood, 110, 2708, 10.1182/blood-2006-11-056101

Charache, 1995, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia, N Engl J Med, 332, 1317, 10.1056/NEJM199505183322001

Steinberg, 2003, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to nine years of treatment, JAMA, 289, 1645, 10.1001/jama.289.13.1645

Maier-Redelsperger, 1999, Long-term hydroxyurea treatment in young sickle cell patients, Curr Opin Hematol, 6, 115, 10.1097/00062752-199903000-00010

Hankins, 2005, Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study, Blood, 106, 2269, 10.1182/blood-2004-12-4973

de Montalembert, 2006, Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes, Haematologica, 91, 125

Grigg, 2007, Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease, Intern Med J, 37, 190, 10.1111/j.1445-5994.2006.01290.x

Halsey, 2003, The role of hydroxyurea in sickle cell disease, Br J Haematol, 120, 177, 10.1046/j.1365-2141.2003.03849.x

Davies, 2003, The role of hydroxyurea in the management of sickle cell disease, Blood Rev, 17, 99, 10.1016/S0268-960X(02)00074-7

Bridges, 1996, A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy, Blood, 88, 4701, 10.1182/blood.V88.12.4701.bloodjournal88124701

Rotter, 2005, Molecular crowding limits the role of fetal hemoglobin in therapy for sickle cell disease, J Mol Biol, 347, 1015, 10.1016/j.jmb.2005.02.006

Adragna, 1994, Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells, Blood, 83, 553, 10.1182/blood.V83.2.553.553

Hillery, 2000, Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin, Br J Haematol, 109, 322, 10.1046/j.1365-2141.2000.02040.x

Styles, 1997, Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea, Blood, 89, 2554, 10.1182/blood.V89.7.2554

Bony, 1999, Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation, Br J Haematol, 107, 263, 10.1046/j.1365-2141.1999.01721.x

Odievre, 2008, Modulation of erythroid adhesion receptors expression by hydroxyurea in children with sickle cell disease, Haematologica, 93, 502, 10.3324/haematol.12070

Schiavone, 1997, 764

Fibach, 1993, Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia, Blood, 81, 1630, 10.1182/blood.V81.6.1630.1630

Wang, 2002, Hydroxyurea exerts bi-modal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways, Br J Haematol, 119, 1098, 10.1046/j.1365-2141.2002.03958.x

Gambero, 2007, Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties, Eur J Haematol, 78, 144, 10.1111/j.1600-0609.2006.00788.x

Okpala, 2002, Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells, Eur J Haematol, 69, 135, 10.1034/j.1600-0609.2002.02775.x

Cokić, 2008, Effects of nitric oxide on red blood cell development and phenotype, Curr Top Dev Biol, 82, 169, 10.1016/S0070-2153(07)00007-5

Wandersee, 2005, Erythrocyte adhesion is modified by alterations in cellular tonicity and volume, Br J Haematol, 131, 366, 10.1111/j.1365-2141.2005.05767.x

Covas, 2004, Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia, Haematologica, 89, 273

Brun, 2003, Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells, Pharmacogenomics J, 3, 215, 10.1038/sj.tpj.6500176

Goodman, 2007, The human red blood cell proteome and interactome, Exp Biol Med, 232, 1391, 10.3181/0706-MR-156